Showing results (181-190 of 798) with videos related to

Sort By:
Pageof 80
Medchemcomm|October 18, 2016
Endless Resistance. Endless Antibiotics?Jed F Fisher, Shahriar Mobashery
Medchemcomm|November 16, 2018
Identification of an auxiliary druggable pocket in the DNA gyrase ATPase domain using fragment probesXiaojie Huang, Junsong Guo, Qi Liu, et al.
Medchemcomm|November 16, 2018
Novel 1,3,4-thiadiazole-chalcone hybrids containing catechol moiety: synthesis, antioxidant activity, cytotoxicity and DNA interaction studiesKatarina Jakovljević, Milan D Joksović, Ivana Z Matić, et al.
Medchemcomm|February 19, 2019
Synthesis and evaluation of novel purple acid phosphatase inhibitorsWaleed M Hussein, Daniel Feder, Gerhard Schenk, et al.
Medchemcomm|February 19, 2019
Synthesis and preliminary evaluation of the anti-cancer activity on A549 lung cancer cells of a series of unsaturated disulfidesFabrizio Olivito, Nicola Amodio, Maria Luisa Di Gioia, et al.
Medchemcomm|February 19, 2019
ADMET-score - a comprehensive scoring function for evaluation of chemical drug-likenessLongfei Guan, Hongbin Yang, Yingchun Cai, et al.
Medchemcomm|February 19, 2019
Crystallographic and SAR analyses reveal the high requirements needed to selectively and potently inhibit SIRT2 deacetylase and decanoylaseLing-Ling Yang, Wei Xu, Jie Yan, et al.
Medchemcomm|April 2, 2019
Synthesis, biological evaluation, and structure activity relationship (SAR) study of pyrrolidine amide derivatives as N-acylethanolamine acid amidase (NAAA) inhibitorsPan Zhou, Lei Xiang, Dongsheng Zhao, et al.
Medchemcomm|July 16, 2019
Aminopyrimidine-galactose hybrids are highly selective galectin-3 inhibitorsAlexander Dahlqvist, Fredrik R Zetterberg, Hakon Leffler, et al.
Medchemcomm|July 16, 2019
Anthranilic amide and imidazobenzothiadiazole compounds disrupt Mycobacterium tuberculosis membrane potentialJake Smith, Heather Wescott, Julie Early, et al.
Pageof 80